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ABSTRACT
Oligonucleotide arrays are powerful tools to study
changes in gene expression for whole genomes.
These arrays can be synthesized by adapting photo-
lithographic techniques used in microelectronics.
Using this method, oligonucleotides are built base
by base directly on the array surface by numerous
cycles of photodeprotection and nucleotide addi-
tion. In this paper we examine strategies to reduce
the number of synthesis cycles required to con-
struct oligonucleotide arrays. By computer model-
ing oligonucleotide synthesis, we found that the
number of required synthesis cycles could be sig-
ni®cantly reduced by focusing upon how oligo-
nucleotides are chosen from within genes and upon
the order in which nucleotides are deposited on the
array. The methods described here could provide a
more ef®cient strategy to produce oligonucleotide
arrays.
INTRODUCTION
The advent of genomics has facilitated a shift in molecular
biology from studies of the expression of single genes to
studies of whole-genome expression pro®les. Genome-wide
expression pro®ling is a powerful tool being applied in gene
identi®cation, drug discovery, pathological and toxicological
mechanisms and clinical diagnosis. By simultaneously meas-
uring the expression of thousands of genes, researchers can get
a picture of the transcriptional pro®le of a whole genome in a
given physiological condition. One of the leading technologies
for expression pro®ling is oligo or gene chips. Oligo chips
consist of oligonucleotides immobilized upon a support
substrate, commonly silica. They have certain advantages
over other technologies. Since all of the oligomers can be
carefully designed, inter-feature variability is low. Also, oligo
chips can be designed to contain several oligonucleotides
representing each gene, allowing more quantitative analysis of
expression levels.
One of the most successful methods used to make
oligonucleotide chips is an adaptation of photolithographic
techniques used in microelectronics (http://www.affymetrix.
com). Initially, a speci®c mask is fabricated for each cycle of
nucleotide addition that permits light to penetrate only at
positions where nucleotides are to be added. A synthesis cycle
consists of shining light through the mask onto the chip
surface. The positions where light passes through the mask
and reaches the chip are activated for synthesis by the removal
of a photolabile protective group from the exposed end of the
oligonucleotide. Thus, the pattern in which light penetrates the
masks directs the base by base synthesis of oligonucleotides
on a solid surface (1). After photodeprotection the chip is
washed in a solution containing a single nucleotide (A, C, G or
T) that binds to oligonucleotides at the deprotected positions.
This method results in the in situ synthesis of oligonucleotides
on an array surface. Light-directed chemical synthesis has
been used to produce arrays with as many as 300 000 features
(up to 1 000 000 on experimental products) with minimal
cross-hybridization or inter-feature variability (2).
When using photolithography to make DNA arrays, the
series of masks and the sequence in which nucleotides are
added de®nes the oligonucleotide products and their locations.
Because a separate photolithographic mask must be designed
for each synthesis cycle it is advantageous to build oligo chips
in as few deposition cycles as possible. To this end, we
developed an algorithm to reduce the number of cycles
required to build an array of oligonucleotides. If the length of
the oligomer is N and the number of possible subunits of the
oligomer is K, our goal was to build a set of oligomers in as
many fewer than N 3 K steps as possible. The simplest
strategy for the in situ synthesis of oligonucleotides upon an
array surface is to ®rst add A everywhere it is needed for the
®rst base, then C, G and T. Using this strategy, a set of
oligonucleotides of length N can be synthesized in a maximum
of 4N steps (3). An array of 25mer oligonucleotides thus
would take 100 cycles to build.
Our strategy reduced the number of required synthesis
cycles by focusing upon two areas of improvement. First, we
focused upon how to best select regions of each gene to be
used for oligonucleotides. From within each gene we selected
oligonucleotides that could be deposited most ef®ciently.
Once the set of oligonucleotides had been selected they could
be deposited on the array surface. The second part of our
strategy was to determine a deposition order of nucleotide
*To whom correspondence should be addressed. Tel: +1 617 253 8686; Fax: +1 617 253 7475; Email: tolonen@mit.edu
ã 2002 Oxford University Press Nucleic Acids Research, 2002, Vol. 30 No. 20 e107
 at Cold Spring H







bases on the array surface with a minimum number of steps.
We allowed the deposition order to vary so as to add the most
common base at each point in the deposition process. During
deposition we added bases at every available position and thus
allowed oligonucleotides to be built at different rates. Thus,
after four cycles, a given oligonucleotide could theoretically
have no bases added and another have four bases. By
simultaneously optimizing oligonucleotide selection and
deposition we signi®cantly reduced the number of deposition
cycles required to synthesize an oligonucleotide array.
MATERIALS AND METHODS
Our strategy consists of two basic parts. Initially, we focused
upon selecting those oligonucleotides from each gene that
could be most ef®ciently deposited upon the array. Second, we
determined an order of oligonucleotide deposition that could
ef®ciently deposit these oligonucleotides. The source code
used in modeling is freely available and can be obtained by
emailing tolonen@mit.edu.
Oligonucleotide selection
First, we determined a candidate set of unique 25mer
oligonucleotides to be deposited on the array. As the input
to our program, we arbitrarily selected the second chromo-
some of Arabidopsis thaliana (ftp://ncbi.nlm.nih.gov/
genbank/genomes/A_thaliana/CHR_II/). This chromosome is
19.6 Mb and contains 4036 genes. In this paper we modeled
the deposition of the ®rst 1000 genes on the chromosome that
were >300 bp. However, our strategy could be applied to any
number of genes in any genome. For each gene we chose ®ve
non-overlapping 25mer oligonucleotides to be deposited on
the array. To de®ne the source for each oligonucleotide we
parsed the 3¢ 300 bp into ®ve 60 bp regions. Thus, each 60 bp
region consisted of a total of 35 potential 25mers. We
subjected each potential oligonucleotide to a series of simple
tests for biological suitability. The tests required that each
oligonucleotide be unique in the genome, have a GC content
between 25 and 75% and have no region of self-comple-
mentarity of ®ve or more bases at either end. In our data set,
2.7% of the 60 bp gene regions contained no suitable
oligonucleotides. From the set of oligonucleotides that passed
the tests, we then selected one oligonucleotide from each
region. Thus, for 1000 genes, we selected a total of 5000
oligonucleotides that were evenly distributed across the 3¢
region of each gene.
Modeling oligonucleotide construction
Once we had selected a complete set of oligonucleotides, the
next step in our method was to evaluate how many deposition
cycles were required to build each oligonucleotide in situ on
an array surface. Broadly, our deposition strategy was to
maximize the number of bases added at each step of the
oligonucleotide synthesis. A position was de®ned as available
if it was the next undeposited base in the oligonucleotide
sequence. During each deposition cycle, we assumed that a
speci®c base could be added only once at an available
position. For example, even if the next two bases to be added
to an oligonucleotide were CC, we added only one C at a time.
For each step of oligonucleotide construction, we identi®ed
the ®rst available base in each oligonucleotide in the data set.
We calculated the frequency of each base at this position and
selected the most common base for deposition. This base was
deposited for each oligonucleotide in which this base occupied
the ®rst position. In each of these oligonucleotides, we then
incremented the next available position by one base. One loop
of our program was analogous to one cycle of oligonucleotide
deposition. The deposition subroutine continued to loop until
we had calculated the total number of steps required to
synthesize each oligonucleotide.
Optimizing oligonucleotide selection
The goal of this section was to see if selecting alternative
oligonucleotides from the same gene region could streamline
the deposition process. We investigated two strategies to
optimize oligonucleotide selection, iterative re-selection and
pooling of candidate oligonucleotides. Our iterative re-
selection strategy identi®ed those oligonucleotides that took
the most steps to build, replaced them with an equivalent
oligonucleotide from the same section of the same gene and
tested if the new set of oligonucleotides could be deposited
more ef®ciently. We viewed this process as analogous to an
`oligonucleotide natural selection' to weed out un®t oligo-
nucleotides and replace them with potentially more ®t
substitutes. After completing an iteration of the deposition
process, we knew the number of steps required to deposit each
oligonucleotide. We identi®ed the 75th percentile as the
number of steps to produce 75% of the oligonucleotides. For
example, if 75% of the oligonucleotides were deposited in 50
steps, we focused upon all oligonucleotides that took 51 or
more steps to deposit. We then replaced all oligonucleotides
above the 75th percentile with alternative oligonucleotides
from the same gene region. We replaced oligonucleotides by
going back to the input sequence and re-selecting an
oligonucleotide that started one position downstream. If that
oligonucleotide passed our biological suitability criteria it was
used instead of the original oligonucleotide in the next
iteration of the deposition process. If the replacement failed
our suitability criteria, then we again replaced this oligo-
nucleotide with one from one base downstream. Our goal was
to converge upon a set of oligonucleotides that could be most
ef®ciently deposited by repeated oligonucleotide re-selection.
Our second method of oligonucleotide optimization was to
initially include all possible 25mer oligonucleotides in the
data set passed to the deposition subroutine and then to select
the oligonucleotide that is deposited in the fewest steps for
each gene region. Thus, all 35 25mers from each gene region
were initially included in the data set. When a single
oligonucleotide was completed from a given gene region it
was selected and the remaining oligonucleotides were deleted
from the data set. After completing the deposition subroutine
we had selected the oligonucleotide from each 60 bp region
that could be deposited in the fewest steps. This method
circumvented the need to iterate the oligonucleotide selection
process.
RESULTS
Our oligonucleotide selection and deposition strategy demon-
strated that oligonucleotides can be synthesized in situ upon an
array in many fewer than 4N steps. In our trial data set, we
deposited all oligonucleotides in 83 steps. To further reduce
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the number of required steps, we investigated the effect of
iterative replacement of the most costly oligonucleotides. We
observed that across iterations the distribution became com-
pressed and the mean number of steps decreased (Fig. 1).
However, even when the oligonucleotide selection process
was iterated 20 times, the number of steps required to
complete the deposition process was not reduced. In fact, it
increased by two cycles. While in the upper tail the
distribution became reduced in size, we were unable to
eliminate those oligonucleotides that required the most steps
to build from the data set. In light of this result, we identi®ed
the gene regions that contained oligonucleotides above the
75th percentile. Because in the upper tail the distribution
diminished in successive iterations, the number of oligo-
nucleotides above the 75th percentile became smaller. It
became clear that the oligonucleotides above the 75th
percentile were coming from the same gene regions across
iterations. Figure 2 is a Venn diagram showing that the most
costly oligonucleotides came from the same gene regions
across iterations. For example, of the 353 oligonucleotides
above the 75th percentile in iteration 20, 263 were from the
same gene regions represented in iteration 1.
As an alternative means to select more ef®cient oligo-
nucleotides, we investigated a pooling approach in which the
initial data set consisted of all potential oligonucleotides from
each gene region. We passed this complete data set to our
deposition subroutine and when a single oligonucleotide from
a given gene region was completed, it was selected and the
remaining oligonucleotides from that gene region were
deleted from the data set. We found that this strategy produced
signi®cant improvements (Fig. 3). Using this strategy, the
entire set of oligonucleotides could be deposited in 73 steps. A
summary comparing the results of these two strategies is
shown in Table 1.
Figure 1. Distribution of the number of steps required to build each oligonucleotide across iterations. Data from iterations 1, 10 and 20 are shown.
As the number of iterations increased, the upper tail of the distribution became compressed. However, the number of cycles required to build the entire
oligonucleotide set did not decrease.
Figure 2. The oligonucleotides requiring the most deposition cycles were
from the same gene regions across iterations. This diagram shows overlap
in the gene regions that contained oligonucleotides above the 75% percen-
tile. Common oligonucleotides: iterations 1 and 10 share 421 common gene
regions; iterations 1 and 20 share 263 gene regions; iterations 10 and 20
share 241 gene regions.
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Our results demonstrate that both oligonucleotide selection
and nucleotide deposition order are important steps towards
minimizing the number of steps required to construct
oligonucleotides in situ upon an array surface. From within
a speci®c gene region, selecting one oligonucleotide versus
another can have a signi®cant impact upon the number of
deposition steps required. Further, the opportunistic deposi-
tion of bases in which the most common next base is added
and oligonucleotides may grow at different rates will almost
always result in fewer deposition steps than when all
oligonucleotides are built at the same rate. Our strategy
minimized the number of required deposition steps by
attempting to simultaneously optimize oligonucleotide selec-
tion and deposition. Because the photolithographic synthesis
of oligonucleotides requires expensive reagents and a custom
mask for each step of synthesis, our methods could reduce the
time and money required to synthesize these arrays.
Our oligonucleotide selection program required that each
oligonucleotide pass a set of criteria for biological suitability
before it was accepted into the data set. Our criteria included
uniqueness in the genome, moderate CG content, no self-
complementarity and availability of a unique mismatch
oligonucleotide. However, our process of oligonucleotide
selection was by no means rigorous. We did not explicitly test
whether the melting temperatures of the oligonucleotides were
similar. Also, cross-hybridization might be better prevented
by searching the genome for regions of signi®cant local
alignment rather than perfect matches.
Our deposition strategy of adding the most common base at
each position can be thought of as similar to a chess game. At
each stage in the game we selected the move that provided the
greatest marginal bene®t. However, an algorithm that could
predict a few steps into the future might be a more optimal
deposition solution. It is easy to see that the number of
pathways for N steps into the future increases at 4N and rapidly
becomes computationally prohibitive. However, we thought
that if we calculated all the possibilities for a few steps ahead
that this might yield some improvement. To this end, we tested
two look-ahead strategies. First, we calculated all the possi-
bilities for four moves ahead and chose the best path for these
four moves. Second, we calculated the best path for the next
four steps, executed a single move, and then re-evaluated the
next move based upon the next four steps. Unfortunately,
neither strategy yielded an improvement.
We found that strategies relating to oligonucleotide selec-
tion can result in a more ef®cient deposition. By replacing all
the oligonucleotides above the 75th percentile, we hoped to
gradually eliminate the most costly oligonucleotides from the
data set. We examined how the distribution of synthesis steps
Figure 3. Distribution of the number of steps required to build each oligonucleotide using the oligonucleotide pooling strategy.
Table 1. Summary of the synthesis cycles required to deposit oligonucle-
otides using the iterative and pooling strategies
Deposition strategy Median cycles Maximum cycles
1 iteration 60 83
10 iterations 60 85
20 iterations 59 85
Pool 54 73
Iterative results are shown for the ®rst, tenth and twentieth iterations. For
each strategy, the number of cycles required to deposit 50% (median) of
oligonucleotides and the number of cycles to deposit all the
oligonucleotides (maximum) are shown.
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required for each oligonucleotide changed as the number of
iterations increased (Fig. 1). We found that reiteration
compressed the distribution and reduced the mean, but it did
not reduce the number of cycles needed to deposit the entire
data set. We believe that this is due to certain genes that have a
small pool of available oligonucleotides. Thus, even if the
process is reiterated, costly oligonucleotides from these genes
cannot be removed from the data set. In light of these results,
we investigated a different strategy in which all the available
oligonucleotides were pooled into the initial data set and
passed to the deposition subroutine. When a single oligo-
nucleotide from a given gene region was completed, it was
selected and the remaining oligonucleotides from that gene
region were deleted. We found that this strategy signi®cantly
reduced the number of required deposition steps (Fig. 3).
Perhaps this is because it is less constrained by those genes
with fewer available oligonucleotides.
Our deposition strategy allowed the oligonucleotides to be
built at different rates. Thus, at any point in the deposition
process the length of an oligonucleotide could be different
from that of its neighbors. Hubbell et al. (4) wrote that it is
usually desirable for the synthesis of adjacent probes to vary in
as few synthesis cycles as possible. They explained that an
undesirable `delta edge' is produced when a monomer is
added to a synthesis region but not to an adjacent region. To
avoid delta edges, it may be important to distribute the
oligonucleotides on the chip surface so that adjacent probes
are built at similar rates.
With regard to oligonucleotide selection, there might be an
unavoidable con¯ict between choosing oligonucleotides to
minimize cross-hybridization and to lower the number of steps
required for deposition. Oligonucleotide probes will more
ef®ciently hybridize with only a single mRNA transcript if
they represent regions of the genome that are speci®c to that
gene. On the other hand, a set of oligonucleotides can be built
in fewer steps if the oligonucleotides are more similar to each
other and thus represent areas that are more conserved among
genes. In our oligonucleotide selection procedure, we tested to
ensure that each oligonucleotide was unique in the genome.
However, the re-selection of oligonucleotides likely selected
for oligonucleotides that were more similar to the rest of
the data set. Thus, our method might result in increased
cross-hybridization on the chip.
In conclusion, the optimal set of oligonucleotides can be
deposited on an array in a minimum number of steps while
retaining the ability to quantify the abundance of each
transcript. Our process produces a set of oligonucleotides
that can be deposited in many fewer than 4N steps. In the
future, we would like to explore whether this process builds a
chip that can effectively monitor changes in global mRNA
expression.
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